A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there ...

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

This discipline includes fundamental research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to these agents.

Yu Televentures is a subsidiary of Micromax Informatics Pvt Ltd. India's largest smartphone maker launched this sub-brand as an online-only venture. Yu makes affordable Android smartphones, sold in ...

Meet BioEmu-1 from Microsoft Research. This deep learning model can generate thousands of protein structures per hour, unlocking new possibilities for protein scientists and drug discovery and ...

The Zhang Legacy Collections Center is home to WMU Archives, Regional History Collections and Special Collections. Named for Charles Zhang and Lynn Chen-Zhang, the Center has more than 30,000 cubic ...

Research interns put inquiry and theory into practice. Alongside fellow doctoral candidates and some of the world’s best researchers, interns learn, collaborate, and network for life. Interns not only ...

Feb. 19, 2025 — The new post-pandemic national hospital occupancy average is 75% -- a full 11 percentage points higher than the pre-pandemic average, largely due to a reduction in staffed ...

Feb. 19, 2025 — Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...